These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20509971)

  • 1. A situational analysis of pharmacovigilance plans in the Global Fund Malaria and U.S. President's Malaria Initiative proposals.
    Stergachis A; Bartlein RJ; Dodoo A; Nwokike J; Kachur SP
    Malar J; 2010 May; 9():148. PubMed ID: 20509971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor support for quality assurance and pharmacovigilance of anti-malarials in malaria-endemic countries.
    Kovacs SD; Mills BM; Stergachis A
    Malar J; 2017 Jul; 16(1):282. PubMed ID: 28693488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
    Mutabingwa TK
    Acta Trop; 2005 Sep; 95(3):305-15. PubMed ID: 16098946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring.
    Kuemmerle A; Dodoo AN; Olsson S; Van Erps J; Burri C; Lalvani PS
    Malar J; 2011 Mar; 10():57. PubMed ID: 21388536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parasites and vectors carry no passport: how to fund cross-border and regional efforts to achieve malaria elimination.
    Gueye CS; Teng A; Kinyua K; Wafula F; Gosling R; McCoy D
    Malar J; 2012 Oct; 11():344. PubMed ID: 23057734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Global Fund and effective malaria treatment.
    Lidén J; Nantulya VM
    Lancet; 2004 Apr; 363(9418):1396. PubMed ID: 15110502
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of the Technical Review Panel of the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria: an analysis of grant recommendations.
    Schmidt-Traub G
    Health Policy Plan; 2018 Apr; 33(3):335-344. PubMed ID: 29309574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Fund investments in human resources for health: innovation and missed opportunities for health systems strengthening.
    Bowser D; Sparkes SP; Mitchell A; Bossert TJ; Bärnighausen T; Gedik G; Atun R
    Health Policy Plan; 2014 Dec; 29(8):986-97. PubMed ID: 24197405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Operational and implementation research within Global Fund to Fight AIDS, Tuberculosis and Malaria grants: a situation analysis in six countries.
    Kiefer S; Knoblauch AM; Steinmann P; Barth-Jaeggi T; Vahedi M; Maher D; Utzinger J; Wyss K
    Global Health; 2017 Mar; 13(1):22. PubMed ID: 28340619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis.
    Olsson S; Pal SN; Stergachis A; Couper M
    Drug Saf; 2010 Aug; 33(8):689-703. PubMed ID: 20635827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.
    Dodoo AN; Fogg C; Asiimwe A; Nartey ET; Kodua A; Tenkorang O; Ofori-Adjei D
    Malar J; 2009 Jan; 8():2. PubMed ID: 19123926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Will a global subsidy of new antimalarials delay the emergence of resistance and save lives?
    Laxminarayan R; Over M; Smith DL
    Health Aff (Millwood); 2006; 25(2):325-36. PubMed ID: 16522574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating operational research in programmes funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria in four sub-Saharan African countries.
    Camacho S; Maher D; Kamau EM; Saric J; Segura L; Zachariah R; Wyss K
    Global Health; 2020 Jul; 16(1):67. PubMed ID: 32711553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The WHO 'Roll Back Malaria Project': planning for adverse event monitoring in Africa.
    Simooya O
    Drug Saf; 2005; 28(4):277-86. PubMed ID: 15783238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conflict-affected displaced persons need to benefit more from HIV and malaria national strategic plans and Global Fund grants.
    Spiegel PB; Hering H; Paik E; Schilperoord M
    Confl Health; 2010 Jan; 4():2. PubMed ID: 20205901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of eliminating malaria and the impact of the global fund in 34 countries.
    Zelman B; Kiszewski A; Cotter C; Liu J
    PLoS One; 2014; 9(12):e115714. PubMed ID: 25551454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global fund financing to the 34 malaria-eliminating countries under the new funding model 2014-2017: an analysis of national allocations and regional grants.
    Zelman B; Melgar M; Larson E; Phillips A; Shretta R
    Malar J; 2016 Feb; 15():118. PubMed ID: 26911998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacovigilance of antimalarial treatment in Africa: is it possible?
    Talisuna AO; Staedke SG; D'Alessandro U
    Malar J; 2006 Jun; 5():50. PubMed ID: 16780575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global fund changes tack on malaria therapy.
    Butler D
    Nature; 2004 Jun; 429(6992):588. PubMed ID: 15190315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.